Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Statera Biopharma, Inc. | ex_168662.htm |
| EX-31.1 - EXHIBIT 31.1 - Statera Biopharma, Inc. | ex_168661.htm |
| EX-21.1 - EXHIBIT 21.1 - Statera Biopharma, Inc. | ex_168659.htm |
| EX-10.22 - EXHIBIT 10.22 - Statera Biopharma, Inc. | ex_179550.htm |
| EX-4.4 - EXHIBIT 4.4 - Statera Biopharma, Inc. | ex_181431.htm |
| 10-K - FORM 10-K - Statera Biopharma, Inc. | cbli20191231b_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNING FIRM
To the Board of Directors and
Stockholders of Cleveland BioLabs, Inc. and Subsidiaries:
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-140687, 333-150542, 333-167415, 333-182466, 333-203631 and 333-225721) and the registration statements on Form S-3 (Nos. 333-192755, 333-202387 and 333-209232) of Cleveland BioLabs, Inc. and Subsidiaries of our report dated April 14, 2020, relating to the consolidated financial statements and financial statement schedules, which appear in this Form 10-K.
MEADEN & MOORE, LTD.
Cleveland, Ohio
April 14, 2020